ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #482Top JournalReview JournalHybrid

Cancer Treatment Reviews

Acronym:ctr
•
Abbreviation (ISO):CANCER TREAT REV
•
Identifier (ISSN):0305-7372(Print)/1532-1967(Online)
•
Publisher:W.B. Saunders Ltd
Clarivate IF (2026)
10.6↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Treatment Reviews

WoS Q1
5914188.1220188.3320198.88202012.1202113.6202211.820239.6202410.5202510.62026
Annual Impact Factor Metric
Current (2026):10.6
Scopus SJR & RankScopus Q1
3.745
#482

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
180

180 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
108articles/year
37.12% Gold OA•0% Original Research

Aims & Scope

Cancer Treatment Reviews Welcome to the online submission and editorial system for Cancer Treatment Reviews. Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews. Each issue provides topical reviews under the following regular sections: • comments on controversy • tumor reviews • anti-tumor treatments • new drugs • complications of treatment • general and supportive care • laboratory/clinic interface.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineGeneticsOncology & Cancer ResearchOncologyPathologySurgeryChemistryBiochemistryCancer ResearchImmunologyPhysicsBioinformatics
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank34/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank53/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF10.6
Articles / Year84
Total Citations73
2025
IF10.5
Articles / Year136
Total Citations1,192
2024
IF9.6
Articles / Year132
Total Citations2,338
2023
IF11.8
Articles / Year107
Total Citations3,159
2022
IF13.608
Articles / Year110
Total Citations5,117

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #482Scopus Q1SCImago Profile
Scopus Coverage:1974-1991, 1993-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
3.745

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
10.64

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,233 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,538
3-Year Documents308
Citable Documents305

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
OncologyQ1
Radiology, Nuclear Medicine and ImagingQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Treatment Reviews (acronym: ctr, abbr: CANCER TREAT REV, ISSN: 0305-7372) is a peer-reviewed international scholarly journal in the field of Medicine, published by W.B. Saunders Ltd in England since 1974. The periodical holds a Journal Impact Factor (JIF) of 10.6, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.745 (Q1), an H-index of 180.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 108 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,233 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
W.B. Saunders Ltd
Publication Language
English
Frequency
Quarterly
Founding Year
1974
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 46bf748c-da38-4955-8d9b-585c6bed900d
Database Updated: 2026-10-16